Dan Stinchcomb: The Passing of a Global Health Leader

March 14th, 2018|Blog|

The world lost a tremendous advocate for global health with the passing of Dan Stinchcomb, PhD, IDRI’s Chief Scientific Officer, who died Feb. 21 after a brief illness. In a short time, he made a tremendous impact on IDRI’s work [...]

Here’s One Thing to Do on Sunday

January 26th, 2018|Blog|

As World Leprosy Day rolls around this year on Sunday, Jan. 28, we have much to be excited about from the scientific standpoint. In October, IDRI announced that our promising leprosy vaccine candidate – the first vaccine developed specifically for [...]

IDRI’s 6th annual Geek Gift Guide

December 6th, 2017|Blog|

The clock is ticking; the pressure is on. It’s time to buy holiday gifts! The question is: what are you going to get your favorite geek? As a scientific organization, IDRI is full of self-proclaimed geeks who have a few [...]

TB and Antimicrobial Resistance Go Hand-in-Hand

November 13th, 2017|Blog|

Every year the World Health Organization releases its global report on tuberculosis. For the past few years, this has provided sobering reading. Tuberculosis is the biggest killer among infectious diseases, surpassing both AIDS and malaria. In 2016, there were 1.7 [...]

Seattle Lawyer Cindy Runger Joins IDRI Board of Directors

October 19th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle, WA | Oct. 19, 2017: Cindy Runger, a senior finance and legal executive who most recently served in a leadership role with U.S. Trust, has joined the Board of Directors of IDRI (Infectious Disease Research [...]

Promising New Leprosy Vaccine Moves into Human Trials

October 12th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE, WA, & GREENVILLE, SC | Oct. 12, 2017: Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a [...]

IDRI Collaborates on Novel Vaccine for Ebola & Other Hemorrhagic Fever Viruses

October 5th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Oct. 5, 2017: IDRI (Infectious Disease Research Institute) is part of a new consortium formed to prepare and test a vaccine formulation designed to protect against the Ebola, Sudan, Marburg, and Lassa fever viruses. If successful, [...]

Quratis Teams with IDRI on TB Vaccine

August 30th, 2017|Press Releases|

SEATTLE & SEOUL | Aug. 30, 2017 FOR IMMEDIATE RELEASE: Quratis Inc. announced Wednesday that the company had applied for the phase 2 of clinical trials in Korea for an adult tuberculosis vaccine developed by scientists at the Infectious Disease Research Institute [...]

IDRI to Continue Development of Inhalable TB Drug Candidate

August 24th, 2017|Press Releases|

  IDRI's Steve Reed, left, signs TB agreement with Hisun officials as part of a ceremony to commemorate the 30th anniversary of the friendship relationship between the state of Indiana and Zheijiang Province. SEATTLE | Aug. 24, 2017 FOR [...]

IDRI Teams with WSOS for Summer Internships for UW Students

July 17th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | July 17, 2017: With a focus on training the next generation of global health scientists, the Infectious Disease Research Institute (IDRI) is partnering with the Washington State Opportunity Scholarship (WSOS) to provide four internships [...]

Load More